Role of serum amyloid A during metabolism of acute-phase HDL by macrophages

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 3, 2000, Pages 763-772

  Artl, Andreas ^a   Marsche, Gunther ^a   Lestavel, Sophie ^b   Sattler, Wolfgang ^a   Malle, Ernst ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b INSTITUT PASTEUR DE LILLE   (France)

Author keywords

Cholesterol metabolism; HDL; Inflammation

Indexed keywords

AMYLOID A PROTEIN; HIGH DENSITY LIPOPROTEIN;

ACUTE PHASE RESPONSE; AMYLOIDOSIS; ANIMAL CELL; ARTICLE; LIPOPROTEIN METABOLISM; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; RABBIT; REGRESSION ANALYSIS;

EID: 0034100717     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.3.763     Document Type: Article

References (76)

1. Uhlar CM, Burgess CJ, Sharp PM, Whitehead AS. Evolution of the serum amyloid A (SAA) protein superfamily. Genomics. 1994;19:228-235.
2. Malle E, Steinmetz A, Raynes JG. Serum amyloid A (SAA): an acute phase protein and apolipoprotein. Atherosclerosis. 1993;102:131-146.
3. Benson MD, Aldo-Benson M. Effect of purified protein SAA on immune response in vitro: mechanisms of suppression. J Immunol. 1979;122: 2077-2082.
4. Zimlichman S, Danon A, Nathan I, Mozes G, Shainkin-Kestenbaum R. Serum amyloid A, an acute phase protein, inhibits platelet activation. J Lab Clin Med. 1990;116:180-186.
5. Brinckerhoff CE, Mitchell TI, Karmilowicz MJ, Kluve-Beckerman B, Benson MD. Autocrine induction of collagenase by serum amyloid A-like and beta 2-microglobulin-like proteins. Science. 1989;243:655-657.
6. Hershkoviz R, Preciado-Patt L, Lider O, Fridkin M, Dastych J, Metcalfe DD, Mekori YA. Extracellular matrix-anchored serum amyloid A preferentially induces mast cell adhesion. Am J Physiol. 1997;42:179-187.
7. Preciado-Patt L, Hershkoviz R, Fridkin M, Lider O. Serum amyloid A binds specific extracellular matrix glycoproteins and induces the adhesion of resting CD4+ T cells. J Immunol. 1996;156:1189-1195.
8. Xu L, Badolato R, Murphy WJ, Longo DL, Anver M, Hale S, Oppenheim JJ, Wang JM. A novel biologic function of serum amyloid A: induction of T lymphocyte migration and adhesion. J Immunol. 1995;155: 1184-1190.
9. Badolato R, Wang JM, Murphy WJ, Lloyd AR, Michiel DF, Bausserman LL, Kelvin DJ, Oppenheim JJ. Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J Exp Med. 1994;180:203-209.
10. Badolato R, Johnston JA, Wang JM, McVicar D, Xu LL, Oppenheim JJ, Kelvin DJ. Serum amyloid A induces calcium mobilization and chemotaxis of human monocytes by activating a pertussis toxin-sensitive signaling pathway. J Immunol. 1995;155:4004-4010.
11. Malle E, Bollmann A, Steinmetz A, Gemsa D, Leis HJ, Sattler W. Serum amyloid A (SAA) protein enhances formation of cyclooxygenase metabolites of activated human monocytes. FEBS Lett. 1997;419:215-219.
12. Akira S, Hirano T, Taga T, Kishimoto T. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J. 1990; 4:2860-2867.
13. Jensen LE, Whitehead AS. Regulation of serum amyloid A protein expression during the acute-phase response. Biochem J. 1998;334: 489-503.
14. Malle E, De Beer FC. Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice. Eur J Clin Invest. 1996;26:427-435.
15. Husebekk A, Skogen B, Husby G, Marhaug G. Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in vivo. Scand J Immunol. 1985;21:283-287.
16. Tape C, Tan R, Nesheim M, Kisilevsky R. Direct evidence for circulating apoSAA as the precursor of tissue AA amyloid deposits. Scand J Immunol. 1988;28:317-324.
17. Benditt EP, Eriksen N, Hanson RH. Amyloid protein SAA is an apoprotein of mouse plasma high density lipoprotein. Proc Natl Acad Sci U S A. 1979;76:4092-4096.
18. Marhaugh G, Sletten K, Husby G. Characterization of amyloid related protein SAA complexed with serum lipoproteins (apoSAA). Clin Exp Immunol. 1982;50:382-389.
19. Clifton PM, Mackinnon AM, Barter PJ. Effects of serum amyloid A protein (SAA) on composition, size, and density of high density lipoproteins in subjects with myocardial infarction. J Lipid Res. 1985;26: 1389-1398.
20. Van Lenten BJ, Hama SY, deBeer FC, Stafforini DM, McIntyre TM, Prescott SM, La Du BN, Fogelman AM, Navab M. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response: loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest. 1995;96:2758-2767.
21. Cabana VG, Gidding SS, Getz GS, Chapmann J, Shulman ST. Serum amyloid A and high density lipoprotein participate in the acute phase response of Kawasaki disease. Pediatr Res. 1997;42:651-655.
22. Acton SL, Scherer PE, Lodish HF, M. Krieger. Expression cloning of SR-BI, a CD-36 related class B scavenger receptor. J Biol Chem. 1994; 269:21003-21009.
23. Plump AS, Erickson SK, Wenig W, Partin JS, Breslow JL, Williams DL. Apolipoprotein A-I is required for cholesteryl ester accumulation in steroidogenic cells and for normal adrenal steroid production. J Clin Invest. 1996;97:2660-2671.
24. Rigotti A, Trigatti B, Babitt J, Penman M, Xu S, Krieger M. Scavenger receptor BI: a cell surface receptor for high density lipoprotein. Curr Opin Lipidol. 1997;8:181-188.
25. Fidge NH. High density lipoprotein receptors, binding proteins, and ligands. J Lipid Res. 1999;40:187-201.
26. Glass C, Pittman RC, Civen M, Steinberg D. Uptake of high-density lipoprotein-associated apoprotein A-I and cholesterol esters by 16 tissues of the rat in vivo and by adrenal cells and hepatocytes in vitro. J Biol Chem. 1985;260:744-750.
27. Acton SL, Rigotti A, Landschulz K, Xu S, Hobbs HH, Krieger M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science. 1996;271:518-520.
28. Ji Y, Jian B, Wang N, Sun Y, Moya ML, Phillips MC, Rothblat GH, Swaney JB, Tall AR. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J Biol Chem. 1997;272: 20982-20985.
29. Kozarsky KF, Donahee MH, Rigotti A, Iqbal SN, Edelman ER, Krieger M. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature. 1997;387:414-417.
30. de la Llera-Moya M, Rothblat GH, Connelly MA, Kellner-Weibel G, Sakr SW, Phillips MC, Williams DL. Scavenger receptor BI (SR-BI) mediates free cholesterol flux independently of HDL tethering to the cell surface. J Lipid Res. 1999;40:575-580.
31. Oram JF. Does serum amyloid A mobilize cholesterol from macrophages during inflammation? Amyloid: Int J Exp Clin Invest. 1996;3:290-293.
32. Gonnerman WA, Lim M, Sipe JD, Haves KC, Cathcart ES. The acute phase response in Syrian hamsters elevates apolipoprotein serum amyloid A (apoSAA ) and disrupts lipoprotein metabolism. Amyloid: Int J Exp Clin Invest. 1996;3:261-269.
33. Kisilevsky R, Subrahmanyan L. Serum amyloid A changes high density lipoprotein's cellular affinity: a clue to serum amyloid A's principal function. Lab Invest. 1992;66:778-785.
34. Kisilevsky R, Lindhorst E, Ancsin JB, Young D, Bagshaw W. Acute phase serum amyloid A (SAA) and cholesterol transport during acute inflammation: a hypothesis. Amyloid: Int J Exp Clin Invest. 1996;3: 252-260.
35. Cabana VG, Siegel JN, Sabesin SM. Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins. J Lipid Res. 1989;30:39-49.
36. Cabana VG, Lukens JR, Rice KS, Hawkins TJ, Getz GS. HDL content and composition in acute phase response in 3 species: triglyceride enrichment of HDL a factor in its decrease. J Lipid Res. 1996;37: 2662-2674.
37. 3+ as a specific probe for time-resolved fluorometric immunoassay. J Immunol Methods. 1995;182:131-144.
38. Malle E, Herz R, Artl A, Ibovnik A, Andreae F, Sattler W. Mapping of antigenic determinants of purified, lipid-free human serum amyloid A (SAA) proteins. Scand J Immunol. 1998;48:557-561.
39. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin reagent. J Biol Chem. 1951;1951:193:265-275.
40. Godenir NL, Jeenah MS, Coetzee GA, Van der Westhuyzen DR, Strachan AF, De Beer FC. Standardisation of the quantitation of serum amyloid A protein (SAA) in human serum. J Immunol Methods. 1985;83:217-225.
41. Sinn HJ, Schrenk HH, Friedrich EA, Via DP, Dresel HA. Radioiodination of proteins and lipoproteins using N-bromosuccinimide as oxidizing agent. Anal Biochem. 1988;170:186-192.
42. Sattler W, Stocker R. Greater selective uptake by HepG2 cells of high-density lipoprotein cholesteryl ester hydroperoxides than of unoxidized cholesteryl esters. Biochem J. 1993;294:771-778.
43. Sattler W, Mohr D, Stocker R. Rapid isolation of lipoproteins and assessment of their peroxidation with high-performance liquid chromatography postcolumn chemiluminescence. Methods Enzymol. 1994;233: 469-489.
44. Jessup W, Mander EL, Dean RT. The intracellular storage and turnover of apolipoprotein B of oxidized LDL in macrophages. Biochim Biophys Acta. 1992;1126:167-177.
45. Pittman RC, Knecht TP, Rosenbaum MS, Taylor CA. A nonendocytotic mechanism for the selective uptake of high density lipoprotein-associated cholesterol esters. J Biol Chem. 1987;262:2443-2450.
46. Mahlberg FH, Romblat GH. Cellular cholesterol efflux: role of cell membrane kinetic pools and interaction with apolipoproteins AI, All, and Cs. J Biol Chem. 1992;267:4551-4550.
47. Johnson WJ, Chacko GK, Phillips MC, Rothblat GH. The efflux of lysosomal cholesterol from cells. J Biol Chem. 1990;265:5546-5553.
48. Malle E, Hazell L, Stocker R, Sattler W, Esterbauer H, Waeg G. Immunologic detection and measurement of hypochlorite-modified LDL with specific monoclonal antibodies. Arterioscler Thromb Vasc Biol. 1995;15: 982-989.
49. Malle E, Heß H, Münscher G, Knipping G, Steinmetz A. Purification of serum amyloid A and its isoforms from human plasma by hydrophobic interaction chromatography and preparative isoelectric focusing. Electrophoresis. 1992;13:422-428.
50. Schneider WJ, Goldstein JL, Brown MS. Purification of the LDL receptor. Methods Enzymol. 1985;109:405-417.
51. 3-associated cholesteryl esters by mouse peritoneal macrophages. J Lipid Res. 1997;38:239-253.
52. Rinninger F, Greten H. High-density lipoprotein particle uptake and selective uptake of high-density lipoprotein-associated cholesteryl esters by J774 macrophages. Biochim Biophys Acta. 1990;1043:318-326.
53. Matsumoto A, Mitchell A, Kurata H, Pyle L, Kondo K, Itakura H, Fidge N. Cloning and characterization of HB2, a candidate high density lipoprotein receptor: sequence homology with members of the immunoglobulin superfamily of membrane proteins. J Biol Chem. 1997;272: 16778-16782.
54. Nion S, Briand O, Lestavel S, Torpier G, Nazih F, Delbart C, Fruchart JC, Clavey V. High-density-lipoprotein subfraction 3 interaction with glycosylphosphatidylinositol-anchored proteins. Biochem J. 1997;328: 415-423.
55. Murao K, Terpstra V, Green SR, Kondratenko N, Steinberg D, Quehenberger O. Characterization of CLA-1, a human homologue of rodent scavenger receptor BI, as a receptor for high density lipoprotein and apoptotic thymocytes. J Biol Chem. 1997;272: 17551-17557.
56. Webb NR, Connell PM, Graf GA, Smart EJ, de Villiers WJ, de Beer FC, van der Westhuyzen DR. SR-BII, an isoform of the scavenger receptor BI containing an alternate cytoplasmic tail, mediates lipid transfer between high density lipoprotein and cells. J Biol Chem. 1998;273:15241-15248.
57. Parks JS, Rudel LL. Alteration of high density lipoprotein subfraction distribution with induction of serum amyloid A protein (SAA) in the nonhuman primate. J Lipid Res. 1985;26:82-91.
58. Geisterfer M, Richards C, Baumann M, Fey G, Gywnne D, Gauldie J. Regulation of IL-6 and the hepatic IL-6 receptor in acute inflammation in vivo. Cytokine. 1993;5:1-7.
59. Lyoumi S, Tamion F, Petit J, Dechelotte P, Dauguet C, Scotte M, Hiron M, Leplingard A, Salier JP, Daveau M, Lebreton JP. Induction and modulation of acute-phase response by protein malnutrition in rats: comparative effect of systemic and localized inflammation on interleukin-6 and acute-phase protein synthesis. J Nutr. 1998;128:166-174.
60. Banka CL, Black AS, Curtiss L. Localization of an apolipoprotein A-I epitope critical for lipoprotein-mediated cholesterol efflux from monocytic cells. J Biol Chem. 1994;269:10288-10297.
61. Fielding PE, Kawano M, Catapano AL, Zoppo A, Marcovina S, Fielding CJ. Unique epitope of apolipoprotein A-I expressed in pre-beta-1 high-density lipoprotein and its role in the catalyzed efflux of cellular cholesterol. Biochemistry. 1994;33:6981-6985.
62. Sviridov D, Pyle L, Fidge N. Identification of a sequence of apolipoprotein A-I associated with the efflux of intracellular cholesterol to human serum and apolipoprotein A-I containing particles. Biochemistry. 1996;35:189-196.
63. Jian B, de la Llera-Moya M, Ji Y, Wang N, Phillips MC, Swaney JB, Tall AR, Rothblat GH. Scavenger receptor class B type I as a mediator of cellular cholesterol efflux to lipoproteins and phospholipid acceptors. J Biol Chem. 1998;273:5599-5606.
64. Sugita Y, Uzawa M, Tomita M. Isolation of decay-accelerating factor (DAF) from rabbit erythrocyte membranes. J Immunol Methods. 1987; 104:123-130.
65. Sloand EM, Maciejewski JP, Dunn D, Moss J, Brewer B, Kirby M, Young NS. Correction of the PNH defect by GPI-anchored protein transfer. Blood. 1998;92:4439-4445.
66. Parolini I, Sargiacomo M, Lisanti MP, Peschle C. Signal transduction and glycophosphatidylinositol-linked proteins (lyn, lck, CD4, CD45, G proteins, and CD55) selectively localize in Triton-insoluble plasma membrane domains of human leukemic cell lines and normal granulocytes. Blood. 1996;87:3783-3794.
67. Nicholson-Weller A, March JP, Rosen CE, Spicer DB, Austen KF. Surface membrane expression by human blood leukocytes and platelets of decay-accelerating factor, a regulatory protein of the complement system. Blood. 1985;65:1237-1244.
68. Rinninger F, Kaiser T, Mann WA, Meyer N, Greten H, Beisiegel U. Lipoprotein lipase mediates an increase in the selective uptake of high density lipoprotein-associated cholesteryl esters by hepatic cells in culture. J Lipid Res. 1998;39:1335-1348.
69. Liang JS, Sipe JD. Recombinant human serum amyloid A (apoSAAp) binds cholesterol and modulates cholesterol flux. J Lipid Res. 1995;36: 37-46.
70. Bielicki JK, McCall MR, Forte TM. Apolipoprotein A-I promotes cholesterol release and apolipoprotein E recruitment from THP-1 macrophage-like foam cells. J Lipid Res. 1999;40:85-92.
71. Banka CL, Yuan T, De Beer MC, Kindy M, Curtiss LK, De Beer FC. Serum amyloid A (SAA): influence on HDL mediated cellular cholesterol efflux. J Lipid Res. 1995;36:1058-1065.
72. Meek RL, Urieli Shoval S, Benditt EP. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. Proc Natl Acad Sci U S A. 1994;91:3186-3190.
73. Liao F, Andalibi A, Qiao J-H, Allayee H, Fogelman Am, Lusis AJ. Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice. J Clin Invest. 1994;94:877-884.
74. Qiao JH, Castellani LW, Fishbein MC, Lusis AJ. Immune-complex-mediated vasculitis increases coronary artery lipid accumulation in autoimmune-prone MRL mice. Arterioscler Thromb. 1993;13:932-943.
75. Urieli-Shoval S, Meek RL, Hanson RH, Eriksen N, Benditt EP. Human serum amyloid A genes are expressed in monocyte/macrophage cell lines. Am J Pathol. 1994;145:650-660.
76. Ray BK, Chatterjee S, Ray A. Mechanism of minimally modified LDL-mediated induction of serum amyloid A gene in monocyte/macrophage cells. DNA Cell Biol. 1999;18:65-73.